Cite

HARVARD Citation

    Bourillon, L. et al. (2019). An auristatin‐based antibody‐drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer. International journal of cancer. 145 (7), pp. 1838-1851. [Online]. 
  
Back to record